Promising diagnostic test for breast cancer brain metastasis never gets off the ground

NCT ID NCT03974204

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study was designed to see if analyzing tiny particles called exosomes in spinal fluid could help doctors diagnose leptomeningeal metastasis—a serious complication where breast cancer spreads to the membranes around the brain and spinal cord. Researchers planned to collect spinal fluid and blood samples from breast cancer patients with suspected spread. However, the study was withdrawn before any participants were enrolled, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Régional Universitaire de Lille

    Lille, Hauts-de-France, 59000, France

  • Centre Oscar Lambret

    Lille, Hauts-de-France, 59020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.